Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the type of ocular inflammation treatment being adopted, considering the range of treatment options, their comparative effectiveness, and convenience in terms of mode of administration.
The global market for ocular inflammation treatment is expected to grow sharply in the coming years. Prominent market players are diversifying their product lines to cater treatment of all forms of uveitis occurring worldwide.
Market Analysis and Insights: Global Ocular Inflammation Treatment Market
The global Ocular Inflammation Treatment market size is projected to reach US$ 21460 million by 2026, from US$ 20230 million in 2020, at a CAGR of 5.5%% during 2021-2026.
Global Ocular Inflammation Treatment Scope and Market Size
Ocular Inflammation Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ocular Inflammation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Allergan Plc.
Cipla Ltd.
Pfizer, Inc.
Novartis AG
Valeant Pharmaceuticals International, Inc.
Alimera Sciences, Inc.
Akorn, Inc.
Abbvie, Inc.
Eyegate Pharmaceuticals, Inc.
pSivida Corporation
Ocular Inflammation Treatment Breakdown Data by Type
Immunosuppressant
Monoclonal Antibodies
Corticosteroids
Cycloplegic Agents
Antibiotics
Analgesics
Antivirals
Antifungal
Ocular Inflammation Treatment Breakdown Data by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores
The global market for ocular inflammation treatment is expected to grow sharply in the coming years. Prominent market players are diversifying their product lines to cater treatment of all forms of uveitis occurring worldwide.
Market Analysis and Insights: Global Ocular Inflammation Treatment Market
The global Ocular Inflammation Treatment market size is projected to reach US$ 21460 million by 2026, from US$ 20230 million in 2020, at a CAGR of 5.5%% during 2021-2026.
Global Ocular Inflammation Treatment Scope and Market Size
Ocular Inflammation Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ocular Inflammation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Allergan Plc.
Cipla Ltd.
Pfizer, Inc.
Novartis AG
Valeant Pharmaceuticals International, Inc.
Alimera Sciences, Inc.
Akorn, Inc.
Abbvie, Inc.
Eyegate Pharmaceuticals, Inc.
pSivida Corporation
Ocular Inflammation Treatment Breakdown Data by Type
Immunosuppressant
Monoclonal Antibodies
Corticosteroids
Cycloplegic Agents
Antibiotics
Analgesics
Antivirals
Antifungal
Ocular Inflammation Treatment Breakdown Data by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ocular Inflammation Treatment Revenue
1.4 Market by Type
1.4.1 Global Ocular Inflammation Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunosuppressant
1.4.3 Monoclonal Antibodies
1.4.4 Corticosteroids
1.4.5 Cycloplegic Agents
1.4.6 Antibiotics
1.4.7 Analgesics
1.4.8 Antivirals
1.4.9 Antifungal
1.5 Market by Application
1.5.1 Global Ocular Inflammation Treatment Market Share by Application: 2020 VS 2026
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Online Pharmacies
1.5.5 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Ocular Inflammation Treatment Market Perspective (2015-2026)
2.2 Global Ocular Inflammation Treatment Growth Trends by Regions
2.2.1 Ocular Inflammation Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ocular Inflammation Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Ocular Inflammation Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ocular Inflammation Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Ocular Inflammation Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Ocular Inflammation Treatment Players by Market Size
3.1.1 Global Top Ocular Inflammation Treatment Players by Revenue (2015-2020)
3.1.2 Global Ocular Inflammation Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Ocular Inflammation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ocular Inflammation Treatment Market Concentration Ratio
3.2.1 Global Ocular Inflammation Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ocular Inflammation Treatment Revenue in 2019
3.3 Ocular Inflammation Treatment Key Players Head office and Area Served
3.4 Key Players Ocular Inflammation Treatment Product Solution and Service
3.5 Date of Enter into Ocular Inflammation Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ocular Inflammation Treatment Historic Market Size by Type (2015-2020)
4.2 Global Ocular Inflammation Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Ocular Inflammation Treatment Market Size by Application (2015-2020)
5.2 Global Ocular Inflammation Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Ocular Inflammation Treatment Market Size (2015-2020)
6.2 Ocular Inflammation Treatment Key Players in North America (2019-2020)
6.3 North America Ocular Inflammation Treatment Market Size by Type (2015-2020)
6.4 North America Ocular Inflammation Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Ocular Inflammation Treatment Market Size (2015-2020)
7.2 Ocular Inflammation Treatment Key Players in Europe (2019-2020)
7.3 Europe Ocular Inflammation Treatment Market Size by Type (2015-2020)
7.4 Europe Ocular Inflammation Treatment Market Size by Application (2015-2020)
8 China
8.1 China Ocular Inflammation Treatment Market Size (2015-2020)
8.2 Ocular Inflammation Treatment Key Players in China (2019-2020)
8.3 China Ocular Inflammation Treatment Market Size by Type (2015-2020)
8.4 China Ocular Inflammation Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Ocular Inflammation Treatment Market Size (2015-2020)
9.2 Ocular Inflammation Treatment Key Players in Japan (2019-2020)
9.3 Japan Ocular Inflammation Treatment Market Size by Type (2015-2020)
9.4 Japan Ocular Inflammation Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Ocular Inflammation Treatment Market Size (2015-2020)
10.2 Ocular Inflammation Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ocular Inflammation Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Ocular Inflammation Treatment Market Size by Application (2015-2020)
11 India
11.1 India Ocular Inflammation Treatment Market Size (2015-2020)
11.2 Ocular Inflammation Treatment Key Players in India (2019-2020)
11.3 India Ocular Inflammation Treatment Market Size by Type (2015-2020)
11.4 India Ocular Inflammation Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Ocular Inflammation Treatment Market Size (2015-2020)
12.2 Ocular Inflammation Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Ocular Inflammation Treatment Market Size by Type (2015-2020)
12.4 Central & South America Ocular Inflammation Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Allergan Plc.
13.1.1 Allergan Plc. Company Details
13.1.2 Allergan Plc. Business Overview
13.1.3 Allergan Plc. Ocular Inflammation Treatment Introduction
13.1.4 Allergan Plc. Revenue in Ocular Inflammation Treatment Business (2015-2020))
13.1.5 Allergan Plc. Recent Development
13.2 Cipla Ltd.
13.2.1 Cipla Ltd. Company Details
13.2.2 Cipla Ltd. Business Overview
13.2.3 Cipla Ltd. Ocular Inflammation Treatment Introduction
13.2.4 Cipla Ltd. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.2.5 Cipla Ltd. Recent Development
13.3 Pfizer, Inc.
13.3.1 Pfizer, Inc. Company Details
13.3.2 Pfizer, Inc. Business Overview
13.3.3 Pfizer, Inc. Ocular Inflammation Treatment Introduction
13.3.4 Pfizer, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.3.5 Pfizer, Inc. Recent Development
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview
13.4.3 Novartis AG Ocular Inflammation Treatment Introduction
13.4.4 Novartis AG Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.4.5 Novartis AG Recent Development
13.5 Valeant Pharmaceuticals International, Inc.
13.5.1 Valeant Pharmaceuticals International, Inc. Company Details
13.5.2 Valeant Pharmaceuticals International, Inc. Business Overview
13.5.3 Valeant Pharmaceuticals International, Inc. Ocular Inflammation Treatment Introduction
13.5.4 Valeant Pharmaceuticals International, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.5.5 Valeant Pharmaceuticals International, Inc. Recent Development
13.6 Alimera Sciences, Inc.
13.6.1 Alimera Sciences, Inc. Company Details
13.6.2 Alimera Sciences, Inc. Business Overview
13.6.3 Alimera Sciences, Inc. Ocular Inflammation Treatment Introduction
13.6.4 Alimera Sciences, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.6.5 Alimera Sciences, Inc. Recent Development
13.7 Akorn, Inc.
13.7.1 Akorn, Inc. Company Details
13.7.2 Akorn, Inc. Business Overview
13.7.3 Akorn, Inc. Ocular Inflammation Treatment Introduction
13.7.4 Akorn, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.7.5 Akorn, Inc. Recent Development
13.8 Abbvie, Inc.
13.8.1 Abbvie, Inc. Company Details
13.8.2 Abbvie, Inc. Business Overview
13.8.3 Abbvie, Inc. Ocular Inflammation Treatment Introduction
13.8.4 Abbvie, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.8.5 Abbvie, Inc. Recent Development
13.9 Eyegate Pharmaceuticals, Inc.
13.9.1 Eyegate Pharmaceuticals, Inc. Company Details
13.9.2 Eyegate Pharmaceuticals, Inc. Business Overview
13.9.3 Eyegate Pharmaceuticals, Inc. Ocular Inflammation Treatment Introduction
13.9.4 Eyegate Pharmaceuticals, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.9.5 Eyegate Pharmaceuticals, Inc. Recent Development
13.10 pSivida Corporation
13.10.1 pSivida Corporation Company Details
13.10.2 pSivida Corporation Business Overview
13.10.3 pSivida Corporation Ocular Inflammation Treatment Introduction
13.10.4 pSivida Corporation Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.10.5 pSivida Corporation Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ocular Inflammation Treatment Revenue
1.4 Market by Type
1.4.1 Global Ocular Inflammation Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunosuppressant
1.4.3 Monoclonal Antibodies
1.4.4 Corticosteroids
1.4.5 Cycloplegic Agents
1.4.6 Antibiotics
1.4.7 Analgesics
1.4.8 Antivirals
1.4.9 Antifungal
1.5 Market by Application
1.5.1 Global Ocular Inflammation Treatment Market Share by Application: 2020 VS 2026
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Online Pharmacies
1.5.5 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Ocular Inflammation Treatment Market Perspective (2015-2026)
2.2 Global Ocular Inflammation Treatment Growth Trends by Regions
2.2.1 Ocular Inflammation Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ocular Inflammation Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Ocular Inflammation Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ocular Inflammation Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Ocular Inflammation Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Ocular Inflammation Treatment Players by Market Size
3.1.1 Global Top Ocular Inflammation Treatment Players by Revenue (2015-2020)
3.1.2 Global Ocular Inflammation Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Ocular Inflammation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ocular Inflammation Treatment Market Concentration Ratio
3.2.1 Global Ocular Inflammation Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ocular Inflammation Treatment Revenue in 2019
3.3 Ocular Inflammation Treatment Key Players Head office and Area Served
3.4 Key Players Ocular Inflammation Treatment Product Solution and Service
3.5 Date of Enter into Ocular Inflammation Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ocular Inflammation Treatment Historic Market Size by Type (2015-2020)
4.2 Global Ocular Inflammation Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Ocular Inflammation Treatment Market Size by Application (2015-2020)
5.2 Global Ocular Inflammation Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Ocular Inflammation Treatment Market Size (2015-2020)
6.2 Ocular Inflammation Treatment Key Players in North America (2019-2020)
6.3 North America Ocular Inflammation Treatment Market Size by Type (2015-2020)
6.4 North America Ocular Inflammation Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Ocular Inflammation Treatment Market Size (2015-2020)
7.2 Ocular Inflammation Treatment Key Players in Europe (2019-2020)
7.3 Europe Ocular Inflammation Treatment Market Size by Type (2015-2020)
7.4 Europe Ocular Inflammation Treatment Market Size by Application (2015-2020)
8 China
8.1 China Ocular Inflammation Treatment Market Size (2015-2020)
8.2 Ocular Inflammation Treatment Key Players in China (2019-2020)
8.3 China Ocular Inflammation Treatment Market Size by Type (2015-2020)
8.4 China Ocular Inflammation Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Ocular Inflammation Treatment Market Size (2015-2020)
9.2 Ocular Inflammation Treatment Key Players in Japan (2019-2020)
9.3 Japan Ocular Inflammation Treatment Market Size by Type (2015-2020)
9.4 Japan Ocular Inflammation Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Ocular Inflammation Treatment Market Size (2015-2020)
10.2 Ocular Inflammation Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ocular Inflammation Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Ocular Inflammation Treatment Market Size by Application (2015-2020)
11 India
11.1 India Ocular Inflammation Treatment Market Size (2015-2020)
11.2 Ocular Inflammation Treatment Key Players in India (2019-2020)
11.3 India Ocular Inflammation Treatment Market Size by Type (2015-2020)
11.4 India Ocular Inflammation Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Ocular Inflammation Treatment Market Size (2015-2020)
12.2 Ocular Inflammation Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Ocular Inflammation Treatment Market Size by Type (2015-2020)
12.4 Central & South America Ocular Inflammation Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Allergan Plc.
13.1.1 Allergan Plc. Company Details
13.1.2 Allergan Plc. Business Overview
13.1.3 Allergan Plc. Ocular Inflammation Treatment Introduction
13.1.4 Allergan Plc. Revenue in Ocular Inflammation Treatment Business (2015-2020))
13.1.5 Allergan Plc. Recent Development
13.2 Cipla Ltd.
13.2.1 Cipla Ltd. Company Details
13.2.2 Cipla Ltd. Business Overview
13.2.3 Cipla Ltd. Ocular Inflammation Treatment Introduction
13.2.4 Cipla Ltd. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.2.5 Cipla Ltd. Recent Development
13.3 Pfizer, Inc.
13.3.1 Pfizer, Inc. Company Details
13.3.2 Pfizer, Inc. Business Overview
13.3.3 Pfizer, Inc. Ocular Inflammation Treatment Introduction
13.3.4 Pfizer, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.3.5 Pfizer, Inc. Recent Development
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview
13.4.3 Novartis AG Ocular Inflammation Treatment Introduction
13.4.4 Novartis AG Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.4.5 Novartis AG Recent Development
13.5 Valeant Pharmaceuticals International, Inc.
13.5.1 Valeant Pharmaceuticals International, Inc. Company Details
13.5.2 Valeant Pharmaceuticals International, Inc. Business Overview
13.5.3 Valeant Pharmaceuticals International, Inc. Ocular Inflammation Treatment Introduction
13.5.4 Valeant Pharmaceuticals International, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.5.5 Valeant Pharmaceuticals International, Inc. Recent Development
13.6 Alimera Sciences, Inc.
13.6.1 Alimera Sciences, Inc. Company Details
13.6.2 Alimera Sciences, Inc. Business Overview
13.6.3 Alimera Sciences, Inc. Ocular Inflammation Treatment Introduction
13.6.4 Alimera Sciences, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.6.5 Alimera Sciences, Inc. Recent Development
13.7 Akorn, Inc.
13.7.1 Akorn, Inc. Company Details
13.7.2 Akorn, Inc. Business Overview
13.7.3 Akorn, Inc. Ocular Inflammation Treatment Introduction
13.7.4 Akorn, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.7.5 Akorn, Inc. Recent Development
13.8 Abbvie, Inc.
13.8.1 Abbvie, Inc. Company Details
13.8.2 Abbvie, Inc. Business Overview
13.8.3 Abbvie, Inc. Ocular Inflammation Treatment Introduction
13.8.4 Abbvie, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.8.5 Abbvie, Inc. Recent Development
13.9 Eyegate Pharmaceuticals, Inc.
13.9.1 Eyegate Pharmaceuticals, Inc. Company Details
13.9.2 Eyegate Pharmaceuticals, Inc. Business Overview
13.9.3 Eyegate Pharmaceuticals, Inc. Ocular Inflammation Treatment Introduction
13.9.4 Eyegate Pharmaceuticals, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.9.5 Eyegate Pharmaceuticals, Inc. Recent Development
13.10 pSivida Corporation
13.10.1 pSivida Corporation Company Details
13.10.2 pSivida Corporation Business Overview
13.10.3 pSivida Corporation Ocular Inflammation Treatment Introduction
13.10.4 pSivida Corporation Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.10.5 pSivida Corporation Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
